Yayınlar & Eserler

Yayın Ağı
Makaleler 48
Tümü (48)
SCI-E, SSCI, AHCI (46)
SCI-E, SSCI, AHCI, ESCI (48)
ESCI (2)
Scopus (47)
TRDizin (1)

1. COST OF CHRONIC MYELOID LEUKAEMIA TREATMENT IN TÜRKIYE: RESULTS OF A DELPHI PANEL APPROACH

Saydam G., Eskazan E., GÜVENÇ B., Sonmez M., Toprak S., Tatar M., et al.
VALUE IN HEALTH , sa.12, 2024 (SCI-Expanded, SSCI, Scopus) identifier

2. The impact of pharmaceutical innovation on health outcomes and utilization in Turkey: A re-examination

Lichtenberg F. R., Tatar M., ÇALIŞKAN Z.
HEALTH POLICY AND TECHNOLOGY , cilt.6, sa.2, ss.226-233, 2017 (SSCI, Scopus) identifier identifier

3. DIRECT COSTS OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) IN TURKEY: A PANEL APPROACH

Tatar M., Tuna E., Senturk A., Sarioz F., Konya A.
VALUE IN HEALTH , cilt.19, sa.7, 2016 (SCI-Expanded, SSCI, Scopus) Creative Commons License identifier

4. ADHERENCE TO GOLD CRITERIA STRATEGY IN TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) PATIENTS: COST IMPLICATIONS IN TURKEY

Tatar M., Tuna E., Senturk A., Sarioz F., Konya A.
VALUE IN HEALTH , cilt.19, sa.7, 2016 (SCI-Expanded, SSCI, Scopus) Creative Commons License identifier

5. DIRECT COST OF HIV/AIDS IN TURKEY

Tatar M., Kockaya G., Ozelgun B., Elbir Z. T., Senturk A., Tuna E., et al.
VALUE IN HEALTH , cilt.19, sa.7, 2016 (SCI-Expanded, SSCI, Scopus) Sürdürülebilir Kalkınma identifier

6. INDIRECT COST OF HIV/AIDS: RESULTS OF A SURVEY FROM A TURKISH RESEARCH CENTER

Tatar M., Kockaya G., Ozelgun B., Elbir Z. T., Senturk A., Tuna E., et al.
VALUE IN HEALTH , cilt.19, sa.7, 2016 (SCI-Expanded, SSCI, Scopus) Sürdürülebilir Kalkınma identifier

7. INDIRECT COSTS OF STROKE IN TURKEY

Tatar M., Arsava E. M., Topcuoglu M. A., Caliskan Z., Karabulut E., Tuna E., et al.
VALUE IN HEALTH , cilt.19, sa.7, 2016 (SCI-Expanded, SSCI, Scopus) Creative Commons License identifier

8. ORPHAN DRUG MARKET ANALYSIS IN TURKEY

Senturk A., Demir O., Tatar M., Ugurlu M., Sivaci C., Biter E., et al.
VALUE IN HEALTH , cilt.19, sa.7, 2016 (SCI-Expanded, SSCI, Scopus) Creative Commons License identifier

9. INDIRECT COSTS OF EPILEPSY IN TURKEY: COST OF THE DISEASE IN TERMS OF WORK LOSS

Tatar M., Senturk A., Tuna E., Gurses C., Caliskan Z., Caglayan B., et al.
VALUE IN HEALTH , cilt.19, sa.7, 2016 (SCI-Expanded, SSCI, Scopus) Creative Commons License identifier

10. COST OF TREATMENT OF HR+/HER2-POST MENOPAUSAL ADVANCED/METASTATIC BREAST CANCER PATIENTS IN TURKEY

Altundag K., Basaran G., Oksuzoglu B., Oven B., Ozguroglu M., Aydin D., et al.
VALUE IN HEALTH , cilt.19, sa.3, 2016 (SCI-Expanded, SSCI, Scopus) Creative Commons License Sürdürülebilir Kalkınma identifier

11. COMPARISON OF SUGAMMADEX AND NEOSTIGMINE USE IN TERMS OF COST SAVINGS IN HOSPITALS IN TURKISH HEALTHCARE SETTING

Tatar M., Tuna E., Senturk A., Alanoglu Z., Aypar U., Degirmenci S., et al.
VALUE IN HEALTH , cilt.19, sa.3, 2016 (SCI-Expanded, SSCI, Scopus) Creative Commons License identifier

12. COST EFFECTIVENESS OF SODIUM OXYBATE IN TREATMENT OF CATAPLEXY IN PATIENTS WITH NARCOLEPY IN TURKEY

Tatar M., Tuna E., Caglayan B., Sarica N., Firidin A.
VALUE IN HEALTH , cilt.18, sa.7, 2015 (SCI-Expanded, SSCI, Scopus) Creative Commons License identifier

13. GENERAL ASSESSMENT OF UNLICENSED MEDICINE USAGE IN TURKEY

Dogan E., Kockaya G., Tuna E., Yenilmez F. B., Vural I. M., Akbulat A., et al.
VALUE IN HEALTH , cilt.18, sa.7, 2015 (SCI-Expanded, SSCI, Scopus) Creative Commons License identifier

14. DIRECT TREATMENT COSTS OF STROKE IN TURKEY

Tatar M., SENTURK A., TUNA E., KARABULUT E., ÇALIŞKAN Z., ARSAVA E. M., et al.
VALUE IN HEALTH , cilt.18, sa.7, 2015 (SCI-Expanded, SSCI, Scopus) Creative Commons License identifier

15. LOCAL COST STUDY OF TREATMENT OF VENOUS THROMBOEMBOLISM IN TURKEY

Tatar M., Senturk A., Tuna E., Bilginer B., Ulus A. T., Buyuktuna N., et al.
VALUE IN HEALTH , cilt.18, sa.7, 2015 (SCI-Expanded, SSCI, Scopus) identifier

16. GENERAL ASSESSMENT OF UNLICENSED ANTINEOPLASTIC AND IMMUNOMODULATING MEDICINE USAGE SUBGROUPS IN TURKEY

Yenilmez F. B., Kockaya G., Dogan E., Tuna E., Vural I. M., Akbulat A., et al.
VALUE IN HEALTH , cilt.18, sa.7, 2015 (SCI-Expanded, SSCI, Scopus) Creative Commons License identifier

17. GENERAL ASESSMENT OF UNLICENSED ANTINEOPLASTIC AND IMMUNOMODULATING MEDICINE USAGE IN TURKEY

Tuna E., Kockaya G., Yenilmez F. B., Dogan E., Vural I. M., Akbulat A., et al.
VALUE IN HEALTH , cilt.18, sa.7, 2015 (SCI-Expanded, SSCI, Scopus) Creative Commons License identifier

18. COST SAVING STUDY OF FIVE GRASS POLLEN SLIT TABLET VERSUS SCIT'S & SYMPTOMATIC TREATMENT

Tatar M., Senturk A., Tuna E., Darrigol S., Girard L., Kayin I.
VALUE IN HEALTH , cilt.18, sa.7, 2015 (SCI-Expanded, SSCI, Scopus) Creative Commons License identifier

19. DEVELOPMENT OF HTA IN TURKEY

Tuna E., Tatar M., Ergin G., Senturk A., Atikeler K.
VALUE IN HEALTH , cilt.17, sa.7, 2014 (SCI-Expanded, SSCI, Scopus) Creative Commons License identifier

20. IMPACT OF HEALTH POLICY CHANGES ON TRENDS OF PHARMACEUTICAL MARKET IN TURKEY

Yilmaz S. E., Kockaya G., Yenilmez F. B., Saylan M., Tatar M., Vural H. E., et al.
VALUE IN HEALTH , cilt.17, sa.7, 2014 (SCI-Expanded, SSCI, Scopus) Creative Commons License Sürdürülebilir Kalkınma identifier

21. COST-EFFECTIVENESS OF OMALIZUMAB IN CHRONIC IDIOPATHIC URTICARIA REFRACTORY TO H1-ANTIHISTAMINES IN TURKEY

Tatar M., Sezen S., Senturk A., Balp M. M., Saylan M., Keskinaslan A.
VALUE IN HEALTH , cilt.17, sa.7, 2014 (SCI-Expanded, SSCI, Scopus) Creative Commons License identifier

22. COST-EFFECTIVENESS OF USE OF BARRICAID (R) IN LUMBAR DISCECTOMY SURGERY IN TURKEY

Tatar M., Senturk A., Dalgali Y.
VALUE IN HEALTH , cilt.17, sa.7, 2014 (SCI-Expanded, SSCI, Scopus) Creative Commons License identifier

23. IMPACT OF HEALTH POLICY CHANGES ON THE COST SALES OF 5 TOP SELLING ATC1 PHRAMACEUTICAL GROUPS IN TURKEY

Yenilmez F. B., Kockaya G., Saylan M., Yilmaz S. E., Tatar M., Vural H. E., et al.
VALUE IN HEALTH , cilt.17, sa.7, 2014 (SCI-Expanded, SSCI, Scopus) Creative Commons License Sürdürülebilir Kalkınma identifier

24. COST-ANALYSIS OF CHRONIC IDIOPATHIC URTICARIA DISEASE

Tatar M., Senturk A., Ergin G., Tuna E., Mat C., Baskan B. E., et al.
VALUE IN HEALTH , cilt.17, sa.7, 2014 (SCI-Expanded, SSCI, Scopus) Creative Commons License identifier

25. VALUE OF LIFE AND COST OF PRE-MATURE DEATHS WITH THE PERSPECTIVE OF PRODUCTIVITY AS NET TAX REVENUE: A COMPARISON IN ARGENTINA, BRAZIL AND MEXICO

Atikeler K., Tuna E., Yenilmez F. B., Tatar M., Kockaya G.
VALUE IN HEALTH , cilt.17, sa.7, 2014 (SCI-Expanded, SSCI, Scopus) Creative Commons License identifier

26. VALUE OF LIFE AND COST OF PRE-MATURE DEATHS WITH THE PERSPECTIVE OF PRODUCTIVITY AS NET TAX REVENUE: A COMPARISON IN USA, CANADA, JAPAN AND AUSTRALIA

Yenilmez F. B., Tuna E., Atikeler K., Kockaya G., Tatar M.
VALUE IN HEALTH , cilt.17, sa.7, 2014 (SCI-Expanded, SSCI, Scopus) Creative Commons License identifier

27. VALUE OF LIFE AND COST OF PRE-MATURE DEATHS WITH THE PERSPECTIVE OF PRODUCTIVITY AS NET TAX REVENUE: A COMPARISON IN FRANCE, GERMANY, ITALY, SPAIN, UNITED KINGDOM

Tuna E., Yenilmez F. B., Atikeler K., Kockaya G., Tatar M.
VALUE IN HEALTH , cilt.17, sa.7, 2014 (SCI-Expanded, SSCI, Scopus) Creative Commons License identifier

28. IMPACT OF HEALTH POLICY CHANGES ON UNIT SALES OF 5 TOP SELLING ATC1 PHRAMACEUTICAL GROUPS IN TURKEY

Saylan M., Yilmaz S. E., Yenilmez F. B., Kockaya G., Tatar M., Vural H. E., et al.
VALUE IN HEALTH , cilt.17, sa.7, 2014 (SCI-Expanded, SSCI, Scopus) Creative Commons License Sürdürülebilir Kalkınma identifier

29. IMPACT OF HEALTH POLICY CHANGES ON THE GROWTH LOCALLY MANUFACTURED AND IMPORTED PHARMACEUTICAL MARKETS OF TOP SELLING ATC1 PHRAMACEUTICAL GROUP (ALIMENTARY AND METABOLISM (A0) IN TURKEY

Kockaya G., Yenilmez F. B., Saylan M., Yilmaz S. E., Tatar M., Vural H. E., et al.
VALUE IN HEALTH , cilt.17, sa.7, 2014 (SCI-Expanded, SSCI, Scopus) Creative Commons License Sürdürülebilir Kalkınma identifier

30. VALUE OF LIFE AND COST OF PRE-MATURE DEATHS WITH THE PERSPECTIVE OF PRODUCTIVITY AS NET TAX REVENUE FOR TURKEY

Kockaya G., Tuna E., Yenilmez F. B., Atikeler K., Tatar M.
VALUE IN HEALTH , cilt.17, sa.7, 2014 (SCI-Expanded, SSCI, Scopus) Creative Commons License identifier

31. IMPACT OF HEALTH POLICY CHANGES ON THE GROWTH LOCALLY MANUFACTURED AND IMPORTED PHARMACEUTICAL MARKETS IN TURKEY

Vural H. E., Kockaya G., Yenilmez F. B., Saylan M., Yilmaz S. E., Tatar M., et al.
VALUE IN HEALTH , cilt.17, sa.7, 2014 (SCI-Expanded, SSCI, Scopus) Creative Commons License Sürdürülebilir Kalkınma identifier

32. AVAILABILITY OF RISK SHARING AGREEMENTS IN THE TURKISH PHARMACEUTICAL SECTOR

Tuna E., Tatar M., Ergin G., Senturk A., Atikeler K.
VALUE IN HEALTH , cilt.17, sa.7, 2014 (SCI-Expanded, SSCI, Scopus) Creative Commons License identifier

33. The effect of pharmaceutical innovation on longevity, hospitalization and medical expenditure in Turkey, 1999-2010

Lichtenberg F. R., Tatar M., ÇALIŞKAN Z.
HEALTH POLICY , cilt.117, sa.3, ss.361-373, 2014 (SCI-Expanded, SSCI, Scopus) identifier identifier identifier

34. Management of diabetes and diabetes policies in Turkey

Tatar M.
GLOBALIZATION AND HEALTH , cilt.9, 2013 (SCI-Expanded, SSCI, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

35. Cost Analysis of Private Hemodialysis Centers in Turkey

TATAR M., Ergin G., Ecder T.
TURKISH NEPHROLOGY DIALYSIS AND TRANSPLANTATION JOURNAL , cilt.22, sa.3, ss.270-282, 2013 (ESCI, Scopus, TRDizin) Sürdürülebilir Kalkınma identifier identifier

36. Integration: the story from health economics and health policy perspective with examples from Turkey and Europe

TATAR M.
INTERNATIONAL JOURNAL OF INTEGRATED CARE , cilt.13, 2013 (SCI-Expanded, SSCI, Scopus) identifier

37. COST ANALYSIS OF DIALYSIS PRACTICE IN TURKEY

Tatar M., Oguzhan E. G., Kockaya G.
VALUE IN HEALTH , cilt.15, sa.7, 2012 (SCI-Expanded, SSCI, Scopus) Creative Commons License identifier

38. COST-EFFECTIVENESS OF AGOMELATINE IN TREATMENT OF MAJOR DEPRESSIVE DISORDERS IN TURKEY

Tatar M., Dilbaz N., Oral E. T., Tan M.
VALUE IN HEALTH , cilt.15, sa.4, 2012 (SCI-Expanded, SSCI, Scopus) Creative Commons License identifier

39. A study on the identification of factors affecting the life quality of breast cancer patients

SOMUNOĞLU İKİNCİ S., TATAR M.
INTERNATIONAL JOURNAL OF PHARMACEUTICAL AND HEALTHCARE MARKETING , cilt.6, sa.4, ss.376-396, 2012 (ESCI, Scopus) Sürdürülebilir Kalkınma identifier identifier

40. Predictors of Informal Health Payments: The Example from Turkey

Ozgen H., ŞAHİN B., Belli P., TATAR M., Berman P.
JOURNAL OF MEDICAL SYSTEMS , cilt.34, sa.3, ss.387-396, 2010 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

41. COST EFFICACY OF USTEKINUMAB IN TREATMENT OF MODERATE TO SEVERE PLAQUE PSORIASIS IN TURKEY

Tatar M., Sarioz F.
VALUE IN HEALTH , cilt.13, sa.3, 2010 (SCI-Expanded, SSCI, Scopus) identifier

42. Colorectal cancer in Turkey: current situation and challenges for the future

TATAR M., Tatar F.
EUROPEAN JOURNAL OF HEALTH ECONOMICS , cilt.10, ss.99-105, 2010 (SSCI, Scopus) Sürdürülebilir Kalkınma identifier identifier

43. COST-EFFECTIVENESS OF SORAFENIB IN UNRESECTABLE AND/OR METASTATIC RENAL CELL CARCINOMA IN TURKEY

Tatar M., Akbulut H.
VALUE IN HEALTH , cilt.12, sa.7, 2009 (SCI-Expanded, SSCI, Scopus) identifier

44. THE USE OF SCREENING FOR EARLY DIAGNOSIS OF BREAST CANCER IN ANKARA

Somunoglu S., TATAR M.
SOCIAL BEHAVIOR AND PERSONALITY , cilt.37, sa.8, ss.1101-1110, 2009 (SSCI, Scopus) Sürdürülebilir Kalkınma identifier identifier

45. Informal payments in the health sector: A case study from Turkey

Tatar M., Ozgen H., Sahin B., Belli P., Berman P.
HEALTH AFFAIRS , cilt.26, sa.4, ss.1029-1039, 2007 (SCI-Expanded, SSCI, Scopus) identifier identifier identifier

46. Factors affecting use of resources for asthma patients

Sahin B., Tatar M.
JOURNAL OF MEDICAL SYSTEMS , cilt.30, sa.5, ss.395-403, 2006 (SCI-Expanded, SSCI, Scopus) identifier identifier identifier

47. Analysis of factors affecting patient satisfaction - Focus on asthma patients

Sahin B., Tatar M.
DISEASE MANAGEMENT & HEALTH OUTCOMES , cilt.14, sa.3, ss.171-183, 2006 (SCI-Expanded, Scopus) identifier identifier

48. Analysis of Factors Affecting Patient Satisfaction A Case Study with Asthma Patients

ŞAHİN B., TATAR M.
Disease Management & Health Outcomes , cilt.14, sa.3, ss.171-183, 2006 (SCI-Expanded)
Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 6

1. HOW PRICING AND REIMBURSEMENT POLICIES AFFECT THE BUDGET IMPACT OF THE TREATMENT OF SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS IN TURKEY

Tatar M., Tuna E., Oguzhan G., Senturk A., Sozeri B., Aktay Ayaz N., et al.
18th ISPOR Annual European Congress, Milan, İtalya, 7 - 11 Kasım 2015, cilt.18, (Özet Bildiri) Creative Commons License identifier

2. COST OF FAMILIAL MEDITERRANEAN FEVER (FMF) DISEASE IN TURKEY

Aksu K., Dokuyucu O., Ertenli A., Gul A., Karaaslan Y., KASAPÇOPUR Ö., et al.
18th ISPOR Annual European Congress, Milan, İtalya, 7 - 11 Kasım 2015, cilt.18, (Özet Bildiri) Creative Commons License identifier

3. Cost of Obesity for Turkey

Kockaya G., Tatar M., Ergin G., Atikeler K., Ozmen M., Gorgun M., et al.
18th World Congress of the International-Federation-for-the-Surgery-of-Obesity-and-Metabolic-Disorders (IFSO), İstanbul, Türkiye, 28 - 31 Ağustos 2013, cilt.23, ss.1143, (Özet Bildiri) Sürdürülebilir Kalkınma identifier

4. Cost of Obesity and Economic Value of Obesity Surgery for Turkey (CEVOS-T)

Tatar M.
18th World Congress of the International-Federation-for-the-Surgery-of-Obesity-and-Metabolic-Disorders (IFSO), İstanbul, Türkiye, 28 - 31 Ağustos 2013, cilt.23, ss.1079, (Özet Bildiri) Sürdürülebilir Kalkınma identifier

5. Economic Value of Obesity Surgery for Turkey

Kockaya G., Atikeler K., Ergin G., Tatar M., Ozmen M., Gorgun M., et al.
18th World Congress of the International-Federation-for-the-Surgery-of-Obesity-and-Metabolic-Disorders (IFSO), İstanbul, Türkiye, 28 - 31 Ağustos 2013, cilt.23, ss.1143, (Özet Bildiri) Sürdürülebilir Kalkınma identifier

6. Operational Cost of Obesity Surgery for Turkey

Kockaya G., Ergin G., Atikeler K., Tatar M., Ozmen M., Gorgun M., et al.
18th World Congress of the International-Federation-for-the-Surgery-of-Obesity-and-Metabolic-Disorders (IFSO), İstanbul, Türkiye, 28 - 31 Ağustos 2013, cilt.23, ss.1142-1143, (Özet Bildiri) Sürdürülebilir Kalkınma identifier
Kitaplar 2

1. Turkish Healthcare Reforms and Reasons for Failure

Tatar M., ERİGÜÇ G.
Health Policy and Economics, Tavakoli Manouche, Davies Huw T.O., Malek Mo, Editör, Routledge Revivals, 2017 Sürdürülebilir Kalkınma identifier

2. Turkey Health Systems in Transition

TATAR M., MOLLAHALİLOĞLU S., ŞAHİN B., AYDIN S., MARESSO A., HERNANDEZ QUEVEDO C.
World Health Organization, Kopenhag, 2011
Metrikler

Yayın

56

Yayın (WoS)

55

Yayın (Scopus)

47

Atıf (WoS)

121

H-İndeks (WoS)

5

Atıf (Scopus)

4

H-İndeks (Scopus)

1

Atıf (Scholar)

255

H-İndeks (Scholar)

4

Atıf (TrDizin)

4

H-İndeks (TrDizin)

1

Atıf (Diğer Toplam)

4

Açık Erişim

31
BM Sürdürülebilir Kalkınma Amaçları